50419-188 NDC - MAGNEVIST ()

Drug Information

  • Product NDC: 50419-188
  • Proprietary Name: Magnevist
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type:
FDA Application Number: NDA019596
Marketing Category: NDA
Start Marketing Date:6/11/2014
End Marketing Date:1/31/2023

Package Information

No. Package Code Package Description Billing Unit
150419-188-0120 CARTON in 1 BOX (50419-188-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSEML
250419-188-0220 CARTON in 1 BOX (50419-188-02) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSEML
350419-188-0520 CARTON in 1 BOX (50419-188-05) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSEML
450419-188-1110 VIAL, PHARMACY BULK PACKAGE in 1 BOX (50419-188-11) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGEML
550419-188-1520 CARTON in 1 BOX (50419-188-15) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSEML
650419-188-365 SYRINGE in 1 BOX (50419-188-36) / 10 mL in 1 SYRINGEML
750419-188-375 SYRINGE in 1 BOX (50419-188-37) / 15 mL in 1 SYRINGEML
850419-188-385 SYRINGE in 1 BOX (50419-188-38) / 20 mL in 1 SYRINGEML
950419-188-4020 CARTON in 1 BOX (50419-188-40) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE
1050419-188-4220 CARTON in 1 BOX (50419-188-42) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE
1150419-188-435 SYRINGE in 1 BOX (50419-188-43) / 10 mL in 1 SYRINGE
1250419-188-4420 CARTON in 1 BOX (50419-188-44) / 20 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSEML
1350419-188-455 SYRINGE in 1 BOX (50419-188-45) / 15 mL in 1 SYRINGE
1450419-188-4620 CARTON in 1 BOX (50419-188-46) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE
1550419-188-475 SYRINGE in 1 BOX (50419-188-47) / 20 mL in 1 SYRINGEML
1650419-188-4810 VIAL, PHARMACY BULK PACKAGE in 1 BOX (50419-188-48) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
1750419-188-4910 VIAL, PHARMACY BULK PACKAGE in 1 BOX (50419-188-49) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE
1850419-188-5810 VIAL, PHARMACY BULK PACKAGE in 1 BOX (50419-188-58) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGEML
1950419-188-812 CARTON in 1 BOX (50419-188-81) / 10 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSEML
2050419-188-822 CARTON in 1 BOX (50419-188-82) / 10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSEML
2150419-188-832 CARTON in 1 BOX (50419-188-83) / 10 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSEML
2250419-188-842 CARTON in 1 BOX (50419-188-84) / 10 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSEML

NDC Record

Field Name Field Value Definition
PRODUCT NDC50419-188The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMagnevistThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE12/14/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE5/30/2022This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA021037This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBayer HealthCare Pharmaceuticals Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC50419-188The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMagnevistThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE6/11/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE1/31/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA019596This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBayer HealthCare Pharmaceuticals Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 7/4/2025

Previous Code
Next Code